Scott Gavura

5PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2026
A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.

|Jun 26, 2024
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.

Qi Guan, Suriya J Aktar, Reka E Pataky

|Apr 26, 2024
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Pam Takhar, Marc Geirnaert, Scott Gavura

|Mar 27, 2024
Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer.

Caroline Muñoz, Xiaochen Tai, Jessica Arias

|May 15, 2023
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Ambica Parmar, Wei Fang Dai, Francois Dionne

Pageof 1

Frequent Collaborators

3 joint publications

Rebecca E Mercer

2 joint publications

Avram Denburg

2 joint publications

Stuart Peacock

2 joint publications

Mina Tadrous